Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes
1 other identifier
observational
56
1 country
2
Brief Summary
The purpose of this study is to examine the relative predictive ability of the derived monitoring instrument to determine post discharge instability and 30-day outcomes in patients discharged with HF. The primary hypothesis is that variables in the monitoring instrument, individually and combined, identify risk for 30-day outcomes. Clinical indicators of dyspnea, fatigue, orthopnea, dyspnea with exertion, daily weight, edema, heart rate, blood pressure, mental condition, medication adherence, and overall well-being will be reported by participants on a daily basis and considered indicators for 30-day outcomes of stability, re-hospitalization, or mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2015
CompletedFirst Posted
Study publicly available on registry
August 19, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2017
CompletedOctober 20, 2017
December 1, 2016
1.6 years
April 14, 2015
October 18, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with adverse events of rehospitalization and/or mortality.
Trial a novel 30-day post-discharge monitoring instrument after hospitalization for heart to evaluate patient status based on patient self-monitoring.
30 days
Interventions
Eligibility Criteria
Patients with heart failure
You may qualify if:
- \> 65 years of age
- male and female patients admitted to the hospital with the primary diagnosis of HF with hospitalization \> 24 hours
- able to read and write in English
- discharged to home environment
You may not qualify if:
- a cardiac transplant candidate
- experienced an acute coronary event within the previous 30 days of index hospitalization
- experienced percutaneous coronary intervention or coronary artery bypass grafting within the previous 30 days of index hospitalization
- end stage renal disease/hemodialysis
- have a left ventricular assist device
- \> 400 lbs
- unable to stand for 90 seconds independently
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Medstar, Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Medstar, Georgetown University Hospital
Washington D.C., District of Columbia, 20057, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2015
First Posted
August 19, 2015
Study Start
January 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 30, 2017
Last Updated
October 20, 2017
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available.